Optimal prostate-specific antigen thresholds for early salvage therapy after robotic-assisted radical prostatectomy

Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0

초록

Purpose Biochemical recurrence (BCR) after radical prostatectomy is defined as prostate-specific antigen (PSA) >0.2 ng/ml with a subsequent increase. However, early salvage therapy at lower PSA levels may improve outcomes. We aimed to evaluate optimal PSA thresholds for predicting BCR after robotic-assisted radical prostatectomy. Methods We retrospectively analyzed 595 patients who underwent robotic-assisted radical prostatectomy by a single surgeon between 2015 and 2019, excluding those with positive lymph nodes. PSA persistence was defined based on the first postoperative PSA measurement at 1 month. BCR was defined as PSA >0.2 ng/ml with a subsequent increase. Patients were stratified into 3 groups: PSA >= 0.03, >= 0.05, and >= 0.1 ng/ml, with a subsequent increase. Kaplan-Meier analysis was used to assess BCR-free survival, with subgroup analysis stratified by the Cancer of the Prostate Risk Assessment-Surgical classification. Results Median follow-up was 4.8 (interquartile range [IQR] 4.2-5.7) years. PSA >= 0.03, >= 0.05, and >= 0.1 ng/ml exhibited a 5-year BCR-free survival of 63.8%, 34.8%, and 0.0%, respectively, and a median time (IQR) of 0.3 (0.2-0.7), 0.8 (0.3-1.7), and 1.6 (0.7-2.8) years. The median time to recurrence was not reached in the PSA >= 0.03 ng/ml group, whereas it was 1.9 (IQR 1.6-2.3) and 0.7 (IQR 0.5-0.8) years for those with PSA >= 0.05 and >= 0.1 ng/ml, respectively. High-risk patients with PSA >= 0.03 ng/ml had significantly shorter survival than did others (median 1.1 years; 5-year rate 17.3%). Notably, the generalizability of these results is limited by the study's retrospective nature. Conclusions BCR occurred in approximately 1 year in patients with PSA >= 0.1 ng/ml and high-risk patients with PSA >= 0.03 ng/ml. Our findings demonstrate that a lower PSA threshold of 0.03 ng/ml effectively sub-stratifies patients at risk for early recurrence. Therefore, early salvage therapy should be considered at lower PSA levels than the conventional definition, particularly for high-risk patients.

키워드

Prostate cancer; Robot-assisted radical prostatectomy; Prostate-specific antigen; Biochemical recurrence; BIOCHEMICAL RECURRENCE; NATURAL-HISTORY; CANCER; PROGRESSION; DEFINITION; GUIDELINES; RISK
제목
Optimal prostate-specific antigen thresholds for early salvage therapy after robotic-assisted radical prostatectomy
저자
Lee, Jong Hoon; Lee, Chung Un; Song, Wan; Kang, Minyong; Sung, Hyun Hwan; Jeon, Hwang Gyun; Jeong, Byong Chang; Seo, Seong Il; Jeon, Seong Soo
DOI
10.1016/j.urolonc.2026.06.029
발행일
2026-09
유형
Review
저널명
Urologic Oncology: Seminars and Original Investigations
권
44
호
9
페이지
522 ~ 527